Literature DB >> 7937316

Influence of alpha-MSH terminal amino acids on binding affinity and biological activity in melanoma cells.

U G Sahm1, G W Olivier, S K Branch, S H Moss, C W Pouton.   

Abstract

The influence of the terminal amino acids of alpha-MSH on its biological action in B16 murine melanoma cells has been systematically studied. Fragments of alpha-MSH lacking various sequences of terminal residues were synthesized by solid-phase peptide synthesis and their binding affinity to melanoma cells was measured using a radioreceptor assay. Biological activity was determined by measuring both tyrosinase activity and melanogenesis. The relative affinities and activities of the fragments generally followed the same pattern as found previously in other assay systems (frog and lizard bioassay and Cloudman S91 mouse melanoma), with the three amino acids at each terminal not being essential for binding and biological activity, although the C-terminal amino acids 11-13 are more important than those in the N-terminus. The differences in biological activity between the fragments can be explained by their relative binding affinities for the receptor.

Entities:  

Mesh:

Substances:

Year:  1994        PMID: 7937316     DOI: 10.1016/0196-9781(94)90202-x

Source DB:  PubMed          Journal:  Peptides        ISSN: 0196-9781            Impact factor:   3.750


  2 in total

1.  Design and characterization of alpha-melanotropin peptide analogs cyclized through rhenium and technetium metal coordination.

Authors:  M F Giblin; N Wang; T J Hoffman; S S Jurisson; T P Quinn
Journal:  Proc Natl Acad Sci U S A       Date:  1998-10-27       Impact factor: 11.205

2.  Identification of tetrapeptides from a mixture based positional scanning library that can restore nM full agonist function of the L106P, I69T, I102S, A219V, C271Y, and C271R human melanocortin-4 polymorphic receptors (hMC4Rs).

Authors:  Erica M Haslach; Huisuo Huang; Marvin Dirain; Ginamarie Debevec; Phaedra Geer; Radleigh G Santos; Marc A Giulianotti; Clemencia Pinilla; Jon R Appel; Skye R Doering; Michael A Walters; Richard A Houghten; Carrie Haskell-Luevano
Journal:  J Med Chem       Date:  2014-05-14       Impact factor: 7.446

  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.